Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Cash Flow Reinvestment Rate
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Reinvestment Rate of 2.29x as of December 2024, reinvesting CN¥107.98 Million (capex CN¥105.31 Million plus investments CN¥-2.66 Million) from operating cash flow of CN¥47.07 Million. Check how high is Suzhou Fushilai Pharmaceutical Co. Ltd.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Explore 301258 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Suzhou Fushilai Pharmaceutical Co. Ltd.. For live market cap and broader valuation context, see 301258 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.29x | CN¥107.98 Million | CN¥47.07 Million | CN¥105.31 Million | ▲ +60.6% |
| 2023 | 1.43x | CN¥135.38 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -82.4% |
| 2022 | 8.10x | CN¥1.22 Billion | CN¥151.19 Million | CN¥50.11 Million | ▲ +1358.8% |
| 2021 | 0.56x | CN¥110.87 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -57.8% |
| 2020 | 1.32x | CN¥219.57 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +17.6% |
| 2019 | 1.12x | CN¥168.45 Million | CN¥150.55 Million | CN¥70.93 Million | — |